Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer

This publication has 11 references indexed in Scilit:

• A dual anti-tumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity
  Clinical Immunology and Immunopathology, 1992
• Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignancies
  The Lancet, 1990
• Cardiorespiratory effects of immunotherapy with interleukin-2.
  Journal of Clinical Oncology, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells
  Annals of Internal Medicine, 1988
• In vivo anti‐tumor activity of combinations of interferon alpha and interleukin‐2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells
  International Journal of Cancer, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Renal Cell Carcinoma: Natural History and Results of Treatment
  Journal of Urology, 1978